 |
Insilicos is developing new biomarkers with the potential to revolutionize medicine, by providing better diagnoses of disease, and by enabling development of new therapies.
We are applying pattern-recognition techniques to proteomics. Pattern-recognition is a mathematical technique to identify patterns in complex data. Proteomics is the study of the different proteins in our bodies, how they break, and how they can be repaired.
Our initial focus is diagnostics and drug research related to cardiovascular disease.
| |
|
Insilicos Awarded Grant to Develop
Cloud Computing Biomarker Search System
Insilicos has been awarded a grant to develop a highly-scalable, cloud computing-based system to search protein databases. The system is intended for use in mass spectrometry proteomics.
Details: News
Insilicos Awarded Grant to
Improve Bioinformatics Software
Insilicos has won a Federal stimulus grant to improve the user interface of a popular open-source system for analyzing biological data.
Details: News
Insilicos, Collaborators Publish Results
of Human Cardiovascular Study
Insilicos and collaborators at the Univeristy of Washington have published results showing that the company's biomarker platform is a rich source of information on human cardiovascular health. The paper correlates changes in high-density lipoprotein (HDL) particles with cardiovascular disease.
Details: News
Insilicos Moves to New offices
Insilicos today announced that it has moved to larger offices in the Uptown neighborhood of Seattle.
Details: News
Insilicos and The Institute for Systems Biology Announce Cloud Computing System
The popular Tran-Proteomic Pipeline software suite is now cloud-computing ready, researchers at Insilicos and the Institute for Systems Biology jointly announced.
Details: News
Insilicos Awarded Grant for
Advanced Statistical Methods
The National Institute of General Medical Sciences has awarded Insilicos a grant to study a statistical method called Least Angle Regression, or LARS. LARS is a technique for producing stable predictions from data with a large number of dimensions. Such data is typical of Insilicos' biomedical research.
Details: News
|
|
|
|
